natgillin/translations-raw huggingface dataset:
Council Regulation (EU) No 557/2014 of 6 May 2014 establishing the Innovative Medicines Initiative 2 Joint Undertaking (OJ L 169, 7.6.2014, p. 54).
Sklep št. 1982/2006/ES Evropskega parlamenta in Sveta z dne 18. decembra 2006 o Sedmem okvirnem programu Evropske skupnosti za raziskave, tehnološki razvoj in predstavitvene dejavnosti (2007–2013) (UL L 412, 30.12.2006, str.
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking, a joint undertaking (JU) between the Commission and the biopharmaceutical industry, will build up on the results of its predecessor, IMI.
1).
IMI2’s objective is to improve the drug development process by supporting more efficient research and development cooperation among academia, small and medium-sized enterprises and the biopharmaceutical industry, in order to deliver better and safer medicines for patients.
Odločba Sveta 2006/971/ES z dne 19. decembra 2006 o posebnem programu „Sodelovanje“ za izvajanje Sedmega okvirnega programa Evropske skupnosti za raziskave, tehnološki razvoj in predstavitvene dejavnosti (2007–2013) (UL L 400, 30.12.2006, str. 86).
IMI2 JU shall contribute to the implementation of Horizon 2020, and in particular the specific objective ‘Health, demographic change and wellbeing for all’ of the priority ‘Societal challenges’.
Odločba Sveta 2006/972/ES z dne 19. decembra 2006 o posebnem programu „Zamisli“ za izvajanje Sedmega okvirnega programa Evropske skupnosti za raziskave, tehnološki razvoj in predstavitvene dejavnosti (2007–2013) (UL L 400, 30.12.2006, str. 243).
Council Regulation (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint Undertaking (OJ L 169, 7.6.2014, p. 130).
Uredba Sveta (ES) št. 71/2008 z dne 20. decembra 2007 o ustanovitvi Skupnega podjetja Čisto nebo (UL L 30, 4.2.2008, str. 1).
Bio-based Industries (BBI) Joint Undertaking is a joint undertaking (JU) between the Commission and the Bio-based industries aiming at contributing to the objectives of the BBI Initiative of a more resource-efficient and sustainable low-carbon economy and increasing economic growth and employment, in particularly in rural areas, by developing sustainable and competitive bio-based industries in Europe based on advanced biorefineries that source their biomass sustainably.
Uredba Sveta (ES) št. 73/2008 z dne 20. decembra 2007 o ustanovitvi Skupnega podjetja za izvajanje skupne tehnološke pobude za inovativna zdravila (UL L 30, 4.2.2008, str.
Council Regulation (EU) No 558/2014 of 6 May 2014 establishing the Clean Sky 2 Joint Undertaking (OJ L 169, 7.6.2014, p. 77).
Uredba Sveta (ES) št. 521/2008 z dne 30. maja 2008 o ustanovitvi Skupnega podjetja za gorivne celice in vodik (UL L 153, 12.6.2008, str.
Clean Sky 2 JU’s objective is to improve the environmental impact of European aeronautical technologies through advanced research and full-scale demonstration in green technology for air transport, thus contributing to the future international competitiveness of the aeronautical sector.
Resolucija Evropskega parlamenta z dne 12. julija 2007 o sporazumu TRIPS in dostopu do zdravil (UL C 175 E, 10.7.2008, str.
The technical activity is developed through different technical areas and aims at building full scale demonstrators in all flying segments.
591).
Clean Sky 2 JU shall contribute to the implementation of Horizon 2020, and in particular the specific objective ‘Smart, green and integrated transport’ of the priority ‘Societal challenges’.
Prispevki iz držav Efte se nanašajo izključno na njihovo sodelovanje pri dejavnostih okvirnega programa, ki niso jedrske narave.
Council Regulation (EU) No 559/2014 of 6 May 2014 establishing the Fuel Cells and Hydrogen 2 Joint Undertaking (OJ L 169, 7.6.2014, p. 108).
Sklep Sveta 87/516/Euratom, EGS z dne 28. septembra 1987 o okvirnem programu dejavnosti Skupnosti na področju raziskav in tehnološkega razvoja (1987–1991) (UL L 302, 24.10.1987, str. 1).
The Fuel Cells and Hydrogen 2 (FCH 2) Joint Undertaking (JU), a public private partnership between the Commission, the industry and the Research Grouping, will build up on the results of its predecessor, set up under the Seventh Framework Programme.
Sklep Sveta 90/221/Euratom, EGS z dne 23. aprila 1990 o okvirnem programu dejavnosti Skupnosti na področju raziskav in tehnološkega razvoja (1990–1994) (UL L 117, 8.5.1990, str. 28).
FCH 2 JU’s objective is to tackle a series of obstacles to the commercialisation of fuel cells and hydrogen technologies by reducing the cost of FCH systems, increasing their efficiency and demonstrating their feasibility, thus paving the way for a strong, sustainable and globally competitive fuel cells and hydrogen sector in the Union.
Sklep Sveta 93/167/Euratom, EGS z dne 15. marca 1993 o prilagoditvi Sklepa 90/221/Euratom, EGS o okvirnem programu dejavnosti Skupnosti na področju raziskav in tehnološkega razvoja (1990–1994) (UL L 69, 20.3.1993, str. 43).
This appropriation is intended to cover the operational costs of the FCH 2 JU.
Sklep št. 1110/94/ES Evropskega parlamenta in Sveta z dne 26. aprila 1994 o četrtem okvirnem programu Evropske skupnosti na področju raziskav, tehnološkega razvoja in predstavitvenih dejavnosti (1994–1998) (UL L 126, 18.5.1994, str. 1).
FCH 2 JU shall contribute to the implementation of Horizon 2020 and, in particular, of the specific objectives ‘Making the transition to a reliable, affordable, publicly accepted, sustainable and competitive energy system’ and ‘Achieving a European transport system that is resource-efficient, environmentally friendly, safe and seamless’ of the priority ‘Societal challenges’.
Sklep št. 2535/97/ES Evropskega parlamenta in Sveta z dne 1. decembra 1997 o drugi prilagoditvi Sklepa št. 1110/94/ES o četrtem okvirnem programu Evropske skupnosti na področju raziskav, tehnološkega razvoja in predstavitvenih dejavnosti (1994–1998) (UL L 347, 18.12.1997, str. 1).
This appropriation is intended to cover expenditure corresponding to revenue giving rise to the provision of additional appropriations from (non-European Economic Area) third parties or third countries participating in projects in the field of research and technological development, for the 2014-2020 period.
Sklep št. 182/1999/ES Evropskega parlamenta in Sveta z dne 22. decembra 1998 o Petem okvirnem programu Evropske skupnosti na področju raziskav, tehnološkega razvoja in predstavitvenih dejavnosti (1998–2002) (UL L 26, 1.2.1999, str. 1).
In accordance with Article 21 of the Financial Regulation, any revenue entered in Items 6 0 1 3, 6 0 1 5, 6 0 1 6, 6 0 3 1 and 6 0 3 3 of the statement of revenue may give rise to the provision of additional appropriations.
Sklep št. 1513/2002/ES Evropskega parlamenta in Sveta z dne 27. junija 2002 o šestem okvirnem programu Evropske skupnosti na področju raziskav, tehnološkega razvoja in predstavitvenih dejavnosti, ki prispeva k oblikovanju Evropskega raziskovalnega prostora in inovacijam (2002–2006) (UL L 232, 29.8.2002, str.
Council Decision 2006/971/EC of 19 December 2006 concerning the Specific Programme Cooperation implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007-2013) (OJ L 400, 30.12.2006, p. 86).
Odločba Sveta 2002/834/ES z dne 30. septembra 2002 o sprejetju posebnega programa za raziskave, tehnološki razvoj in predstavitev: „Povezovanje in krepitev evropskega raziskovalnega prostora (2002–2006)“ (UL L 294, 29.10.2002, str.
Council Decision 2006/972/EC of 19 December 2006 concerning the Specific Programme: Ideas implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) (OJ L 400, 30.12.2006, p. 243).
1).
Council Regulation (EC) No 71/2008 of 20 December 2007 setting up the Clean Sky Joint Undertaking (OJ L 30, 4.2.2008, p. 1).
Odločba Sveta 2002/835/ES z dne 30. septembra 2002 o sprejetju posebnega programa za raziskave, tehnološki razvoj in predstavitev: „Oblikovanje evropskega raziskovalnega prostora (2002–2006)“ (UL L 294, 29.10.2002, str.
Council Regulation (EC) No 73/2008 of 20 December 2007 setting up the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines (OJ L 30, 4.2.2008, p. 38).
44).
Council Regulation (EC) No 521/2008 of 30 May 2008 setting up the Fuel Cells and Hydrogen Joint Undertaking (OJ L 153, 12.6.2008, p. 1).
Sklep št. 1209/2003/ES Evropskega parlamenta in Sveta z dne 16. junija 2003 o sodelovanju Skupnosti v programu raziskav in razvoja s ciljem razviti nove klinične posege za boj proti HIV/AIDS-u, malariji in tuberkulozi z dolgoročnim partnerstvom med Evropo in državami v razvoju, ki ga izvaja več držav članic (UL L 169, 8.7.2003, str.
European Parliament resolution of 12 July 2007 on the TRIPS Agreement and access to medicines (OJ C 175 E, 10.7.2008, p. 591).
1).
The contributions from EFTA States relate exclusively to their participation in the non-nuclear activities of the framework programme.
V okviru nedokončane agende razvojnih ciljev tisočletja je spodbujanje imunizacije mater, s katero se nosečnice in njihove otroke zaščiti pred boleznimi, ki povzročajo veliko obolevnost in smrtnost, kot so malarija, HIV, tuberkuloza, gripa ali tetanus, izjemna priložnost za učinkovit napredek pri zdravju žensk in otrok (razvojna cilja tisočletja št. 4 in 5) na stroškovno učinkovit in enakopraven način.
Council Decision 87/516/Euratom, EEC of 28 September 1987 concerning the framework programme of Community activities in the field of research and technological development (1987 to 1991) (OJ L 302, 24.10.1987, p. 1).
Cepiva sodijo med najučinkovitejša orodja za preprečevanje in omejevanje nalezljivih bolezni ter z njimi povezanih zapletov in posledic.
Council Decision 90/221/Euratom, EEC of 23 April 1990 concerning the framework programme of Community activities in the field of research and technological development (1990 to 1994) (OJ L 117, 8.5.1990, p. 28).
Učinki večine bolezni, ki jih je mogoče preprečiti s cepljenjem med nosečnostjo, so najhujši pri materah in otrocih iz držav z nizkimi dohodki.
Council Decision 93/167/Euratom, EEC of 15 March 1993 adapting Decision 90/221/Euratom, EEC concerning the Framework Programme of Community activities in the field of research and technological development (1990 to 1994) (OJ L 69, 20.3.1993, p. 43).
Imunizacija mater je obetaven pristop, pri katerem se cepi nosečnice, da bi zaščitili novorojenčke, ki jih ni mogoče cepiti, saj so premladi.
Decision No 1110/94/EC of the European Parliament and of the Council of 26 April 1994 concerning the fourth framework programme of the European Community activities in the field of research and technological development and demonstration (1994 to 1998) (OJ L 126, 18.5.1994, p. 1).
Ocenjuje se, da vsako leto umre 600000 dojenčkov, te smrti pa so posledica okužb, ki bi jih bilo vsaj deloma mogoče preprečiti z imunizacijo mater.
Decision No 2535/97/EC of the European Parliament and of the Council of 1 December 1997 adapting for the second time Decision No 1110/94/EC concerning the fourth framework programme of the European Community activities in the field of research and technological development and demonstration (1994 to 1998) (OJ L 347, 18.12.1997, p. 1).
Poleg tega bi bilo mogoče tako preprečiti nekatere od približno 965000 smrti, ki so posledica predčasnih rojstev, in zmanjšati število rojstev mrtvih otrok zaradi nalezljivih bolezni, ki znaša od 10 do 50 %.
Decision No 182/1999/EC of the European Parliament and of the Council of 22 December 1998 concerning the fifth framework programme of the European Community for research, technological development and demonstration activities (1998 to 2002) (OJ L 26, 1.2.1999, p. 1).
Razpoložljivi dokazi s teh območij o bremenu bolezni, ki jih je mogoče preprečiti z imunizacijo mater, ter o varnosti in učinkovitosti cepiv pri nosečnicah pa so danes nepopolni in nezadostni.
Decision No 1513/2002/EC of the European Parliament and of the Council of 27 June 2002 concerning the sixth framework programme of the European Community for research, technological development and demonstration activities, contributing to the creation of the European Research Area and to innovation (2002 to 2006) (OJ L 232, 29.8.2002, p. 1).
Pridobivanje dobrih podatkov in trdnih dokazov o bremenu bolezni, ki jih je mogoče preprečevati s cepljenjem med nosečnostjo in zgodnjim otroštvom, je v državah z nizkimi dohodki bistvenega pomena in je pogoj za oblikovanje načrta za politiko imunizacije mater na teh območjih.
Council Decision 2002/834/EC of 30 September 2002 adopting a specific programme for research, technological development and demonstration: ‘Integrating and strengthening the European Research Area’ (2002-2006) (OJ L 294, 29.10.2002, p. 1).
Namen: opredelitev bremena bolezni, ki jih je mogoče preprečevati s cepljenjem, pri nosečnicah in njihovih otrocih v državah z nizkimi dohodki ter ocena vpliva simptomov spremljevalnih bolezni, kot so HIV, tuberkuloza in Chagasova bolezen, na to breme.
Council Decision 2002/835/EC of 30 September 2002 adopting a specific programme for research, technological development and demonstration: ‘structuring the European Research Area’ (2002-2006) (OJ L 294, 29.10.2002, p. 44).
Cilji: na podlagi nedavnih dokazov bo pilotni projekt poskušal količinsko opredeliti breme bolezni, ki jih je mogoče preprečiti s cepljenjem (s poudarkom na Guillain-Barréjevem sindromu, respiratornem sincicijskem virusu, oslovskem kašlju, gripi, tetanusu in rdečkah), pri nosečnicah in dojenčkih ter preučiti, kako na to breme vplivajo simptomi spremljevalnih bolezni, kot so okužba s HIV, tuberkuloza ali sočasna okužba s HIV in tuberkulozo, na reprezentativnih območjih v podsaharski Afriki, Latinski Ameriki in Karibih.
Decision No 1209/2003/EC of the European Parliament and of the Council of 16 June 2003 on Community participation in a research and development programme aimed at developing new clinical interventions to combat HIV/AIDS, malaria and tuberculosis through a long-term partnership between Europe and developing countries, undertaken by several Member States (OJ L 169, 8.7.2003, p. 1).
Pilotni projekt utegne prispevati tudi k ocenjevanju dovoljenih cepiv in cepiv, ki se še razvijajo, pri nosečnicah v državah z nizkimi dohodki, kjer so takšna cepiva najbolj potrebna (npr. prispeva lahko k oblikovanju platforme za imunizacijo mater pred gripo, ki bo vključevala prenatalno oskrbo v državah v razvoju), odpravljanju ovir za izvajanje imunizacije mater ter k opredelitvi načrta za politike imunizacije mater in zagotavljanju podatkov za določanje s tem povezanih prednostih nalog.
In the context of the unfinished agenda of the Millennium Development Goals (MDG), stepping up maternal immunisation for pregnant women and their babies, to protect them from diseases that cause substantial morbidity and mortality, such as malaria, HIV, tuberculosis, influenza and tetanus, represents a unique opportunity to effectively advance women's and children's health (MDGs 4 and 5) in a cost-effective and equitable fashion.
Poleg tega projekt prihaja ob pravem času glede na zagnanost svetovnih zdravstvenih deležnikov glede učinkov imunizacije in dejstvo, da bodo države z nizkimi in srednjimi dohodki skozi celotno prihodnje desetletje v svoje programe redne imunizacije uvajale nova cepiva, ki bodo reševala življenja.
Vaccines are among the most effective preventive tools available to date for reducing infectious diseases and their complications and sequelae.
Projekt lahko sproži javno-zasebno sodelovanje in sodelovanje na področju raziskav med severnimi in južnimi državami.
Most diseases that can be prevented with vaccines in pregnancy have the greatest and most serious impact on mothers and infants in low-income countries.
Osnovne raziskave na ravni Unije o stanju v posameznih državah članicah, da se opredelijo področja, kjer bi bilo mogoče ukrepati, oziroma sprejmejo politične odločitve.
Maternal immunisation is a promising approach in which pregnant women are vaccinated in order to protect newborns who are too young to be vaccinated themselves.
Predlagane raziskave so popolna novost, saj združujejo akustično (srednje in oddaljeno polje) in optično (bližnje polje) slikanje (slaba vidljivost, visoke frekvence) z visoko ločljivostjo in z mehanizmom zlivanja in umerjanja, kar omogoča pretvorbo podatkov iz bližnjega polja v oddaljeno in obratno.
Neonatal mortality includes an estimated 600000 infection-related deaths per year, a proportion of which may be addressed through maternal immunisation.
Ta proračunska sredstva bodo med drugim namenjena kritju stroškov biometričnih meritev rib, modeliranja razmerij med starostjo in dolžino rib, biomaso, volumnom ter sliko/videom, količinske opredelitve učinka grebena z označevanjem, umerjanja (združevanja) bioloških rezultatov z akustičnimi in optičnimi, optimiziranja raziskave iz biološkega zornega kota, migracije in ločitve posamezne ribe (sledenje ribi v srednjem do oddaljenem polju), nadzora instrumentov na osnovi dogodka, ocenjevanja razdalje (stereometrika v bližnjem polju), ločevanja rib (sledenje ribi v bližnjem polju) in umerjanja (združevanja) optičnih rezultatov z akustičnimi in biološkimi.
In addition, maternal immunisation may address a proportion of the estimated 965000 deaths from pre-term birth and prevent a proportion of the 10-50 % of stillbirths estimated to be caused by infectious disease.
Namenjene so količinskemu spremljanju števila rib, biomase in biotske raznovrstnosti na ključnih in drugih območjih okvirne direktive o morski strategiji (z nadaljnjim naborom (okoljskih) instrumentov).
In contrast, the evidence currently available from the areas concerned on the burden of diseases that can be prevented through maternal immunisation and on the safety and efficacy of vaccines in pregnant women is incomplete and poor.
Namesto posnetkov (kot pri rednih raziskavah) bodo ustvarjeni videoposnetki, ocenjevalna metoda pa bo v skladu z mednarodnimi standardi (ICES).
The generation of good data and robust evidence on the burden of vaccine-preventable diseases in pregnancy and infancy in low-income countries is vital and is a prerequisite for the future definition of a road map for maternal immunisation policies in those areas.
Sistem naj bi deloval avtonomno, nepretrgano in neinvazivno, sprožili pa ga bodo dogodki, kar bo omogočilo varčevanje z energijo (Je to riba ali kaj drugega?
Goal: to determine the burden of vaccine-preventable diseases in pregnant women and their infants in low-income countries and assess the impact of co-morbidities such as HIV, tuberculosis and Chagas disease on this burden.
Če je riba, vklopi instrumente).
Objectives: capitalising on recent evidence, the pilot project will quantify the burden of vaccine-preventable diseases (with a primary focus on Guillain-Barré Syndrome, respiratory syncytial virus, pertussis, influenza, tetanus and rubella) in pregnant women and their infants and to study how this burden in pregnant women is modified by co-morbidities such as infection by HIV, tuberculosis or joint HIV-tuberculosis infection in representative sites in sub-Saharan Africa, Latin America and the Caribbean.
Podvodni opazovalnici rib v sistemu se bosta „učili“ medsebojne komunikacije in izmenjave pomembnih informacij (na primer v zvezi z učinki grebena).
The pilot project may also help to foster evaluation of licensed vaccines and vaccines under development for pregnant women in low-income countries, where these vaccines are most needed (i.e. it can help build a maternal influenza immunisation platform including antenatal care in developing countries), address obstacles to maternal immunisation, and contribute to the definition of a roadmap on maternal immunisation policies and inform priority setting in these contexts.
Ta proračunska sredstva bodo med drugim namenjena kritju stroškov biometričnih meritev rib, modeliranja razmerij med starostjo in dolžino rib, biomaso, volumnom ter sliko/videom, količinske opredelitve učinka grebena z označevanjem, umeritve (združitve) bioloških rezultatov z akustičnimi in optičnimi, optimiziranja raziskave iz biološkega zornega kota, migracije in ločitve posamezne ribe (sledenje ribi v srednjem do oddaljenem polju), nadzora instrumentov na osnovi dogodka, ocenjevanja razdalje (stereometrika v bližnjem polju), umeritve (združitve) optičnih rezultatov z akustičnimi in biološkimi, strojne opreme in tehničnega senzorskega vmesnika.
Moreover the project is timely, given the momentum among global health stakeholders as regards the impact of immunisation and the fact that, throughout the next decade, low- and middle-income countries will be introducing new life-saving vaccines into their routine immunisation programmes.
Pomembno vprašanje, ki se je pojavilo v zadnjih letih, se nanaša na rekonstrukcijo klitorisa po pohabljanju ženskih spolnih organov.
The project may trigger public-private collaboration and North-South research cooperation.
Rekonstrukcija klitorisa je sorazmerno nova kirurška metoda in čeprav je opaziti interes za ta poseg, manjkajo dokazi o njegovi varnosti in učinkovitosti.
Basic research at Union level into the status quo in all Member States to identify areas for action or draw political conclusions.
Stopnja kratkoročnih in dolgoročnih zapletov in dolgoročni rezultati, vključno s spolno funkcijo, telesno samopodobo in spolom, pa tudi socialno in estetsko identiteto, so bili večkrat navedeni kot raziskovalna vrzel za prihodnost.
The proposed research is completely new in so far as it synchronously combines highly resolved acoustical (medium to far field) and optical (near field) imaging (low light, high frequencies) through a blending and calibration mechanism to translate the information from the near field into the far field and vice versa.
Natančneje povedano, ni jasno, kakšne koristi bi lahko imele ženske od tega posega in ali ne bi bila morda boljša alternativna nega, na primer psihoseksualna terapija.
This is to quantify fish abundance, biomass, and diversity in key areas as well as other MSFD indicators (through a further set of (environmental) instrumentation).
Predlagani projekt bo poskusil odgovoriti na spodnja vprašanja.
As a research platform an opto-acoustic lander hardware (underwater fish observatory, UFO) will be provided by the research institute at no cost for the project, for optimising the pattern recognition algorithms and related research.
In nazadnje, oblikovali bomo priporočila za najboljšo prakso glede smernic za nego na področju rekonstrukcije klitorisa v Uniji.
The indicated amount covers inter alia the costs for biometrical measurements of fish, modelling of fish age-, length-, biomass-, volume-to-photo/video relationships, quantification of the reef effect through tagging experiments, calibration (integration) of biological results with those from acoustics and optics, optimisation of survey design from a biological perspective, migration and single fish separation (medium to far field fish tracing), event based control of the full instrumentation, distance estimation (near field stereo-metrics), fish separation (near field fish tracing) and calibration (integration) of optical results with those from acoustics and biology.
POGLAVJE 08 03 —
This is to quantify fish abundance, biomass, and diversity in key areas as well as other MSFD indicators (through a further set of (environmental) instrumentation).
Odhodki iz poslovanja za program Euratom
Instead of snapshots (as generated like in regular surveys) ‘videos’ will be produced, where the assessment method will be following international (ICES) standards.
Euratom – Fuzijska energija
The complete system is anticipated to work autonomously, continuously and non-invasively in an event based mode to save energy (Is that fish or something else?
Euratom – Jedrska fisija in zaščita pred sevanjem
If fish, then switch on the full instrumentation).
Člen 08 03 01 – Vmesni seštevek
The two underwater fish observatories of the test array will be trained to learn talking to each other and exchanging relevant information (for instance, related to the reef effect).
Člen 08 03 50 – Vmesni seštevek